Rigel Pharmaceuticals, Inc. (RIGL) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with…
Source: Yahoo Finance
Sector & Industry
Rigel Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Rigel Pharmaceuticals, Inc. at a Glance
| Company | Rigel Pharmaceuticals, Inc. |
| Ticker | RIGL |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $48.67 |
| Market cap | $909.15M |
| P/E ratio (trailing) | 2.88 |
| EPS (trailing) | $16.89 |
| 52-week high | $52.24 |
| 52-week low | $24.95 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.20 |
| Return on equity (ROE) | 126.90% |
| Debt-to-equity | 9.39% |
| Average volume | 342,526 |
| Shares outstanding | 18.68M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 172 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Rigel Pharmaceuticals, Inc.'s current P/E ratio?
- Rigel Pharmaceuticals, Inc. (RIGL) has a trailing P/E ratio of 2.88 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Rigel Pharmaceuticals, Inc.'s market capitalisation?
- Rigel Pharmaceuticals, Inc.'s market cap is $909.15M based on our latest snapshot. See how it ranks by market cap →
- What is RIGL's 52-week range?
- Over the past 52 weeks, RIGL has traded between $24.95 and $52.24. What does the 52-week range mean? →
- How volatile is Rigel Pharmaceuticals, Inc. compared to the market?
- Rigel Pharmaceuticals, Inc. has a beta of 1.20, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Rigel Pharmaceuticals, Inc. pay a dividend?
- Rigel Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is RIGL listed on?
- RIGL is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Rigel Pharmaceuticals, Inc. in?
- Rigel Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →